BridgeBio Pharma, Inc.
BBIO· Nasdaq
BridgeBio Pharma, Inc.
- Last sale
- Oct 2, 2026 · +0.49%
- Market cap
- $13.14B
- 195.49M shares
- Filings
- 828
Price
Oct 2, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $502,076,000 | reported | |
| FY 2024 | 2024-12-31 | $221,902,000 | reported | |
| FY 2023 | 2023-12-31 | $9,303,000 | reported | |
| FY 2022 | 2022-12-31 | $77,648,000 | reported | |
| FY 2021 | 2021-12-31 | $69,716,000 | reported | |
| FY 2020 | 2020-12-31 | $8,249,000 | reported | |
| FY 2019 | 2019-12-31 | $40,560,000 | reported |
BridgeBio Pharma, Inc. · CIK 1743881 · Engraved from SEC EDGAR
